Fri.Sep 17, 2021

FDA advisers support booster dose of Pfizer vaccine in older or high-risk adults

Bio Pharma Dive

In a back-and-forth meeting Friday, the committee opposed clearing a third shot widely for use in people older than 16, but agreed the benefits outweighed the risks for adults over 65 or those at risk of severe COVID-19

Infants exposed to domestic violence have poorer cognitive development

Scienmag

COLUMBIA, Mo. While assessing a pregnant woman with premature labor in 1983, Linda Bullock noticed bruises on the woman. When she asked what happened, the woman told Bullock a refrigerator had fallen on her while cleaning the kitchen. Credit: MU COLUMBIA, Mo.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biogen says experimental pain drug helps neuropathy patients in mid-stage trial

Bio Pharma Dive

With Aduhelm approved but struggling to gain traction, Biogen is talking up its pipeline. Mixed trial results, however, may make it challenging to design a larger study that can persuade regulators to approve the pain drug

Pfizer Vaccine Protection Wanes, C.D.C. Study Shows

NY Times

The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination. Vaccination and Immunization Drugs (Pharmaceuticals) Research BioNTech SE Centers for Disease Control and Prevention Pfizer Inc

Lilly's COVID-19 antibody cleared by FDA for post-exposure prevention

Bio Pharma Dive

The expanded authorization comes amid surging demand for antibody treatments, particularly in states with lower rates of coronavirus vaccination

Novartis says its radioligand therapy boosts health-related quality of life

Pharma Times

177Lu-PSMA-617 is being evaluated for the treatment of metastatic castration-resistant prostate cancer

87

ALS Association Pressures FDA to Approve Amylyx Drug as Agency Cuts Phase III Trial Requirement

XTalks

The ALS Association is pushing for rapid FDA approval of Amylyx Pharmaceuticals Inc.’s s candidate drug AMX0035 (sodium phenylbutyrate/taurursodiol) for the treatment of amyotrophic lateral sclerosis, or ALS.

More Trending

Here’s the Story Behind World Patient Safety Day 2021

XTalks

World Patient Safety Day 2021 is celebrated on September 17 worldwide. This day raises global awareness about patient safety and calls for solidarity from all counties to reduce patient harm. September 17 is an official global public health campaign marked by the World Health Organization (WHO).

Drugs 80

Novavax joins Oxford mix-and-match COVID-19 vaccine study in adolescents

Pharma Times

The Phase II clinical trial will include at least 360 adolescents aged 12-16 years old

Follicular Lymphoma Market Size Anticipates Growth as the Key Companies Explores Novel Therapeutics Assets

Delveinsight

Follicular lymphoma, a sub-type of indolent B cell non-Hodgkin lymphoma (NHL), accounts for approximately 20% of the total NHL cases. It is the most frequently diagnosed indolent lymphoma. On average, each year, 15,000 new Follicular lymphoma cases are diagnosed in the US alone.

2021 PM Society Digital Awards winners announced

Pharma Times

Leading the agency side, Havas Life Medicom came out on top with three Gold award wins

76

FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations

BioTech 365

FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older … Continue reading → Business Wire

52

Study: Ignoring black peers leads whites to poor decisions

Scienmag

A study by a University of Texas at Dallas researcher published Sept. 17 in the journal Science Advances identifies a pattern of racial attention deficit, shedding light on why diversity efforts in organizations often fail.

Ipsen: ESMO 2021: Cabometyx® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer

BioTech 365

Ipsen: ESMO 2021: Cabometyx® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer Ipsen: ESMO 2021: Cabometyx® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in … Continue reading → Business Wire

52

New nano particles suppress resistance to cancer immunotherapy

Scienmag

A specially designed lipid nanoparticle could deliver immune-signaling molecules into liver macrophage cells to overcome resistance to anti-tumor immunotherapy. Credit: Takashi Nakamura, et al. Journal for ImmunoTherapy of Cancer. July 2, 2021.

Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer

BioTech 365

Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Exelixis Announces U.S.

5 Henry Ford Hospitals earn top quality recognition for stroke care excellence

Scienmag

DETROIT – All of Henry Ford Health System’s five hospitals that are equipped to treat stroke earned Gold Plus and Honor Roll status for stroke care excellence from the American Heart Association and American Stroke Association.

52

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

BioTech 365

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend WALTHAM, Mass.–(BUSINESS –(BUSINESS WIRE)–PerkinElmer, Inc.

UTA developing sensor network to monitor climate change effects in coastal Texas town

Scienmag

A University of Texas at Arlington civil engineer is working with a Texas coastal town to develop a low-cost sensor network that will help the community monitor climate change effects.

DPharm: Disruptive Innovations US

ERT

Join ERT’s Kristen Sowalsky, PhD, on September 29th at 3:05pm ET for a look at how advances in wearable technologies provide new opportunities to objectively quantify patient functional mobility. Learn More. The post DPharm: Disruptive Innovations US appeared first on ERT.

52

Registration opens: IOP Publishing’s free-to-attend Environmental Research 2021 conference

Scienmag

Taking place virtually between 15 and 19 November, participants will connect with leading experts to debate the direction and effectiveness of the latest environmental scientific research and work together to inspire global action.

Six AmeriHealth Caritas Medicaid Plans Recognized by NCQA for Multicultural Health Care Excellence

BioTech 365

52

NSF EPSCoR grant will advance manufacturing of renewable and recyclable plastics

Scienmag

Plastics are an indispensable part of today’s society. These nimble polymers help keep foods fresh, cars safe, arteries clog-free and have countless other uses. But the benefits come at a cost.

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful and durable response in patients with HER2-positive advanced gastric cancer in DESTINY-Gastric02 Phase II trial

BioTech 365

Better support for long-term symptoms is needed to help patients live life after cancer

Scienmag

Lugano, Switzerland, 18 September 2021 – Previous standards of cancer follow-up care and support may no longer meet current needs as improvements in screening practices, early diagnosis and treatment of cancer have put long-term survival beyond five years following diagnosis within reach for more than half of patients in Europe. (1)

ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial

BioTech 365

Discovery highlights the complex lifestyles of frontline immune cells

Scienmag

WEHI researchers have made a surprise discovery about how immune ‘sentinel’ cells are maintained, which could have implications for drugs in development for treating cancer.

Drugs 52

Walgreens Announces New Bonuses and Rewards to Further Support and Recognize Team Members

BioTech 365

Walgreens Announces New Bonuses and Rewards to Further Support and Recognize Team Members Walgreens Announces New Bonuses and Rewards to Further Support and Recognize Team Members Team members will also receive an incentive for getting vaccinated against COVID-19 DEERFIELD, Ill.–(BUSINESS

A research group has successfully used ultra-small testing technologies to measure the coatings on ferritic steel.

Scienmag

Coating protects structural materials from harsh environments. It is vital for things such as gas turbines, where components can reach high temperatures, or first walls in nuclear fusion reactors.

Bioscience Association Manitoba Announces Report Identifying Risks to the Supply Chain of PPE In Manitoba

BioTech 365

52

Fiber tracking method delivers important new insights into turbulence

Scienmag

Whether it’s heart murmurs and pipeline transport of oil, or bumpy airplanes and the dispersal of pollutants, turbulence plays an important role in many everyday events.

EQRx Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021

BioTech 365

EQRx Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021 EQRx Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab … Continue reading → Business Wire

52

New physics research reveals fresh complexities about electron behavior in materials

Scienmag

When electrons flow through a conductor — such as the copper wires in our phone chargers or the silicon chips in the circuit boards of our laptops — they collide with material impurities and with each other in a tiny atomic frenzy. Their interaction with impurities is well known.

Can-Fite to Participate in Three Upcoming Pharma Partnering Conferences

BioTech 365

Can-Fite to Participate in Three Upcoming Pharma Partnering Conferences Can-Fite to Participate in Three Upcoming Pharma Partnering Conferences Company has received ~$20 million to date from partnering deals with additional potential for up to $130 million, plus royalties based on … Continue reading → Business Wire

52

Study finds surprising early COPD risks for US Hispanics/Latinos

Scienmag

15, 2021? A new study published online in the Annals of the American Thoracic Society provides the most exhaustive look to date at the risk factors, prevalence and population attributable risk (PAR) of developing chronic obstructive pulmonary disease (COPD) in U.S. Hispanics/Latinos under age 50.

Alvotech Welcomes Positive CHMP Opinion for AVT02, a Proposed Biosimilar to Humira®

BioTech 365

Scientific paper urges nutrition scientists to advocate for sustainable food systems

Scienmag

Key Points: Credit: Map: W.A. Masters, Y. Bai and A.